BRNX on Nasdaq
BRENX LTD.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Babcock & Wilcox, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-3291.5%Operating margin2
-3593.0%Net margin2
-398.0%Return on equity2
1.48×Debt to equity2
-$10.4MFree cash flow2
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue48¢$3.6M
- Research and development52¢$4.0M
Out of $387.0K in revenue.2 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| REVENUES | $387.0K | $621.0K | |
| COST OF REVENUES | -$3.6M | -$985.0K | -$1.6M |
| RESEARCH AND DEVELOPMENT, NET | -$4.0M | -$3.6M | -$3.2M |
| SELLING AND MARKETING | -$1.2M | -$1.2M | -$1.1M |
| GENERAL AND ADMINISTRATIVE | -$4.3M | -$4.6M | -$4.6M |
| OTHER INCOME (EXPENSES), NET | $1.0K | -$234.0K | $37.0K |
| OPERATING LOSS | -$12.7M | -$10.6M | -$9.9M |
| INTEREST EXPENSES | -$374.0K | -$244.0K | -$100.0K |
| OTHER FINANCIAL INCOME )EXPENSES(, NET | -$670.0K | $4.0M | $312.0K |
| FINANCIAL INCOME (EXPENSES), NET | -$1.0M | $3.8M | $212.0K |
| SHARE IN EQUITY LOSS OF JOINT VENTURE | -$123.0K | ||
| NET LOSS | -$13.9M | -$6.8M | -$9.6M |
| NET LOSS ATTRIBUTABLE TO ORDINARY SHAREHOLDERS | -$23.4M | -$6.8M | -$9.7M |
| BASIC LOSS ATTRIBUTIBLE TO ORDINARY SHAREHOLDERS | -$57.14 | -$45.27 | -$174.63 |
| DILUTED LOSS ATTRIBUTIBLE TO ORDINARY SHAREHOLDERS | -$57.14 | -$45.27 | -$174.63 |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC LOSS PER SHARE (in Shares) | 408.8K shares | 149.6K shares | 55.8K shares |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF DILUTED LOSS PER SHARE (in Shares) | 408.8K shares | 149.6K shares | 55.8K shares |
| OTHER COMPREHENSIVE LOSS - EXCHANGE DIFFERENCES ON TRANSLATION TO PRESENTATION CURRENECY | -$476.0K | ||
| COMPREHENSIVE LOSS | -$13.9M | -$6.8M | -$10.1M |
No quarterly figures reported.
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $4.9M | $4.1M | $3.2M |
| Restricted deposits | $36.0K | $29.0K | |
| Prepaid expenses and other receivables | $436.0K | $604.0K | |
| Inventory | $1.6M | $1.6M | |
| TOTAL CURRENT ASSETS | $7.0M | $6.3M | |
| Restricted deposits | $98.0K | $86.0K | |
| Operating lease right-of-use assets, net | $901.0K | $560.0K | |
| Property, plant and equipment, net | $4.4M | $4.9M | |
| Investment in joint venture | $177.0K | $74.0K | |
| TOTAL NON-CURRENT ASSETS | $5.5M | $5.6M | |
| TOTAL ASSETS | $12.5M | $11.9M | |
| Trade payables | $133.0K | $276.0K | |
| Deferred revenue | $667.0K | $387.0K | |
| Other payables | $2.4M | $1.6M | |
| Current maturities of European Investment Bank (EIB) Loan | $1.5M | ||
| Current maturities of operating lease liabilities | $542.0K | $501.0K | |
| TOTAL CURRENT LIABILITIES | $5.2M | $2.8M | |
| European Investment Bank (EIB) Loan | $3.4M | $4.3M | |
| Share based payment liability | $300.0K | ||
| Warrants liability | $10.0K | ||
| Operating lease liabilities | $382.0K | $19.0K | |
| TOTAL NON-CURRENT LIABILITIES | $3.8M | $4.6M | |
| TOTAL LIABILITIES | $9.0M | $7.4M | |
| Ordinary Shares, no par value - Authorized 150,000,000 and 15,000,000 as of December 31, 2025 and December 31, 2024, respectively ; Issued and outstanding 715,852 and 231,280 as of December 31, 2025 December 31, 2024, respectively | $124.0K | $124.0K | |
| Additional paid in capital | $121.5M | $108.6M | |
| Foreign currency cumulative translation reserve | -$2.1M | -$2.1M | |
| Accumulated deficit | -$116.1M | -$102.2M | |
| TOTAL SHAREHOLDERS EQUITY | $3.5M | $4.5M | $2.9M |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $12.5M | $11.9M | |
| Ordinary shares, shares authorized | 150.0M shares | 15.0M shares | |
| Ordinary shares, shares issued | 715.9K shares | 231.3K shares | |
| Ordinary shares, shares outstanding | 715.9K shares | 231.3K shares | |
| Preferred Shares, shares authorized | 25.0K shares | 0 shares | |
| Preferred Shares, shares issued | 5.0K shares | 0 shares | |
| Preferred Shares, shares outstanding | 5.0K shares | 0 shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net Loss, as above | -$13.9M | -$6.8M | -$9.6M |
| Depreciation (Note 7) | $561.0K | $228.0K | $120.0K |
| Non-cash interest and exchange rate differences, net | $567.0K | -$101.0K | -$94.0K |
| Fair value adjustment of warrants liability | -$10.0K | -$4.1M | |
| Share in equity loss of joint venture | $123.0K | ||
| Warrants issuance costs | $473.0K | ||
| Share-based compensation (Note 11D) | $1.2M | $1.4M | $1.8M |
| Other | $237.0K | -$35.0K | |
| Decrease in prepaid expenses and receivables | $168.0K | $141.0K | $456.0K |
| Decrease (increase) in inventory | -$13.0K | -$961.0K | $295.0K |
| Increase (decrease) in trade payables | -$9.0K | -$206.0K | $81.0K |
| Increase in other payables and deferred revenue | $912.0K | $178.0K | $122.0K |
| Net cash used in operating activities | -$10.4M | -$9.5M | -$6.9M |
| Purchase of equipment | -$13.0K | -$37.0K | -$33.0K |
| Sale of equipment | $43.0K | ||
| Investment in joint venture | -$226.0K | -$78.0K | |
| Installation of a production facility | -$204.0K | -$306.0K | -$2.6M |
| Participation of Israeli Innovation Authority in production facility investment | $57.0K | ||
| Restricted deposit funded | -$12.0K | -$1.0K | |
| Other | $2.0K | ||
| Net cash used in investing activities | -$398.0K | -$422.0K | -$2.6M |
| Proceeds from issuance of ordinary shares, preferred shares, warrants and prefunded warrants | $12.1M | $8.7M | $6.4M |
| Proceeds from issuance of warrants liability | $3.2M | ||
| Fund raising and issuance costs | -$683.0K | -$939.0K | -$176.0K |
| Grants recognized as liability for royalties | $94.0K | ||
| Exercise of options, prefunded warrants and warrants | $3.0K | $104.0K | |
| Net cash provided by financing activities | $11.5M | $10.9M | $6.4M |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED DEPOSITS | $703.0K | $1.0M | -$3.2M |
| EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS AND RESTRICTED DEPOSITTS | $112.0K | -$97.0K | -$156.0K |
| Recognition of operating lease liability and right-of-use asset | $912.0K | $22.0K | $199.0K |
| Borrowing costs capitalized | $53.0K | $175.0K | |
| Reclassification of share options and warrants from liabilities to equity | $706.0K | $516.0K | |
| Suppliers credit for the acquisition of equipment | $161.0K | ||
| Conversion of unpaid salary to Ordinary Shares and warrants | $228.0K | ||
| Deemed Dividend For Down-round Adjustments | $9.4M | $92.0K | |
| Reclassification of warrants from equity to liabilities | $1.6M | ||
| Interest (net of amounts capitalized) | $236.0K | $183.0K | $113.0K |
Former names
- Brenmiller Energy Ltd.Jan 19, 2022 to Aug 7, 20263
Recent filings
- Oct 14, 2026424B5 PROSPECTUS SUPPLEMENT
- Oct 14, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Oct 2, 2026EFFECT
- Sep 25, 2026F-3 REGISTRATION STATEMENT
- Sep 17, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Sep 15, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Sep 9, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Sep 9, 2026EFFECT
- Aug 31, 2026F-3 REGISTRATION STATEMENT
- Aug 28, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Aug 19, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
- Aug 13, 2026S-8 REGISTRATION STATEMENT
- Aug 7, 20266-K REPORT OF FOREIGN PRIVATE ISSUER
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBRENX LTD. filings on SEC EDGAR
- 2SEC EDGARBRENX LTD. 10-K for fiscal 2025
- 3SEC EDGARBRENX LTD. filings on SEC EDGAR
- 4SEC EDGARBRENX LTD. 10-K for fiscal 2021
- 5SEC EDGARBRENX LTD. 10-K for fiscal 2022
- 6SEC EDGARBRENX LTD. 10-K for fiscal 2020